3D remodelled DNA helix structure
About us We want to help people do more, feel better, live longer.
Today there are still millions of people without access to basic healthcare, thousands of diseases without adequate treatments and millions more people who suffer from everyday ailments. At GSK we want to change this.
Read morePress releases
- GSK announces results from 10-year continuation study showing sustained disease control with Benlysta (belimumab) in SLE
- GSK and MMV announce positive headline phase III results showing single-dose tafenoquine reduces risk of relapse in patients with Plasmodium vivax malaria
- Four innovations to tackle under-five deaths win US$1 million Healthcare Innovation Award from GSK and Save the Children
Tweets from GSK
-
GSK @GSK
“Research, early stage & big pharma working together -like we have on this panel- will increase success of deals” -… twitter.com/i/web/status/8…
about 5 hours ago -
GSK @GSK
“We used to call it the Sand Hill shuffle” - Jay @AvalonVentures on how far tech has taken business partnering loca… twitter.com/i/web/status/8…
about 5 hours ago -
GSK @GSK
Partnerships are critical to scientific success - that why we build relationships w/ the local biotech and scientif… twitter.com/i/web/status/8…
about 6 hours ago
